Try our beta test site
62 studies found for:    ovarian cancer recurrence | Open Studies
Show Display Options
Rank Status Study
1 Recruiting Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence
Condition: First Recurrence of Ovarian Cancer
Interventions: Procedure: Secondary citoreduction;   Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)
2 Recruiting The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer
Condition: Ovarian Neoplasms
Intervention: Other: Determination of CA 125 and HE4, Computed tomography
3 Not yet recruiting Multi-maintenance Olaparib After Disease Recurrence in Participants With Platinum Sensitive BRCAm High Grade Serous Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Olaparib;   Drug: Cediranib;   Drug: Platinum-based Chemotherapy
4 Recruiting Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: Cancer treatment
5 Recruiting Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Conditions: Adnexal Mass;   Borderline Ovarian Epithelial Tumor;   Ovarian Clear Cell Tumor;   Ovarian Endometrioid Tumor;   Ovarian Neoplasm;   Ovarian Serous Tumor;   Recurrent Ovarian Carcinoma
Interventions: Drug: Dexamethasone;   Other: Laboratory Biomarker Analysis;   Drug: Valproic Acid
6 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
7 Recruiting Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor
Conditions: Ovarian Epithelial Cancer Recurrent;   Platinum-resistant
Intervention: Device: Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin
8 Recruiting Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Hyperthermic intraperitoneal chemotherapy (HIPEC);   Drug: Carboplatin
9 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
10 Recruiting Phase 3 Trial of Maintenance Vigil for High Risk Stage IIIb-IV Ovarian Cancer
Conditions: Ovarian Cancer;   Ovarian Neoplasms
Interventions: Biological: Vigil;   Biological: Placebo
11 Recruiting Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer
Intervention: Drug: Omega Nutrition cold-milled flaxseeds
12 Recruiting Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
Conditions: Low-grade Serous Ovarian Carcinoma;   Recurrent Invasive Borderline Serous Ovarian Cancer
Intervention:
13 Not yet recruiting Phase 1b/2 Study of Avelumab With or Without Entinostat in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Peritoneal Cancer;   Fallopian Tube Cancer
Interventions: Drug: entinostat;   Drug: avelumab;   Drug: Placebo
14 Recruiting KOrean Borderline Ovarian Tumor (KOBOT) Registry
Condition: Ovarian Neoplasms
Intervention:
15 Recruiting Biomarker Guided Treatment in Gynaecological Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Biomarker (ER/PR) guided lymphadenectomy;   Drug: Biomarker guided weekly taxane treatment in endometrial/ ovarian cancer
16 Recruiting Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Etoposide, Cyclophosphamide, Carboplatin
17 Recruiting The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
Condition: Ovarian Cancer
Intervention:
18 Recruiting Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: OPT-822/OPT-821
19 Recruiting Intra-peritoneal Chemotherapy in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Immune Tolerance;   Neoplasms;   Effects of Chemotherapy
Intervention:
20 Not yet recruiting Improving Quality of Care for Patients With Recurrent Ovarian Cancer
Conditions: Ovarian Neoplasms;   Quality of Life
Intervention: Other: Questionnaires

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.